RecruitingNot ApplicableNCT07045597
Intranasal Midazolam for Preanasthetic Sedation for Preschool Children Undergoing Adenotonsillectomy.
Sponsor
Sohag University
Enrollment
100 participants
Start Date
Mar 13, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
This study aims to evaluate the effectiveness of Intranasal Midazolam as preanasthetic sedation for preschool children (2-6)y undergoing adenotonsillectomy.
Eligibility
Min Age: 2 YearsMax Age: 6 Years
Inclusion Criteria3
- pediatric patient of age 2-6 y
- ASA I-II children
- child scheduled for elective adenoidectomy , tonsillectomy and adenotonsillectomy
Exclusion Criteria5
- Parent refusal .
- Allergy to any of the drug included in this study
- Nasal infection , allergy and pathology
- Mentally affected children , neurological disable .
- Blood disesases and any other contraindications of surgery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGintranasal normal saline for preanasthetic sedation for Adenotonsillectomy
preschool children that will undergo adenotonsillectomy will receive intranasal normal saline equivalent volume who take midazolam intranasal by dose 1 ml saline by insulin syringe as a control group
DRUGintranasal midazolam for preanasthetic sedation for Adenotonsillectomy
preschool children that will undergo adenotonsillectomy will receive intranasal midazolam by dose 0.2 mg/kg
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07045597